239 related articles for article (PubMed ID: 26742713)
21. In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [
Ghai A; Fettig N; Fontana F; DiPersio J; Rettig M; Neal JO; Achilefu S; Shoghi KI; Shokeen M
EJNMMI Res; 2021 Sep; 11(1):97. PubMed ID: 34586539
[TBL] [Abstract][Full Text] [Related]
22. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
Long Y; Lv X; Song X; Shao F; Ji H; Zhang Y; Qiao P; Liu Q; Xia X; Lei P; Gai Y; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4156-4170. PubMed ID: 35790537
[TBL] [Abstract][Full Text] [Related]
23. In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against alpha4beta1 integrin.
Peng L; Liu R; Andrei M; Xiao W; Lam KS
Mol Cancer Ther; 2008 Feb; 7(2):432-7. PubMed ID: 18245670
[TBL] [Abstract][Full Text] [Related]
24. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
25. Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival.
Hathi D; Chanswangphuwana C; Cho N; Fontana F; Maji D; Ritchey J; O'Neal J; Ghai A; Duncan K; Akers WJ; Fiala M; Vij R; DiPersio JF; Rettig M; Shokeen M
Sci Rep; 2022 Jan; 12(1):30. PubMed ID: 34996933
[TBL] [Abstract][Full Text] [Related]
26. In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.
Zwingenberger AL; Kent MS; Liu R; Kukis DL; Wisner ER; DeNardo SJ; Taylor SL; Chen X; Lam KS
PLoS One; 2012; 7(4):e34404. PubMed ID: 22545083
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.
Herrmann K; Lapa C; Wester HJ; Schottelius M; Schiepers C; Eberlein U; Bluemel C; Keller U; Knop S; Kropf S; Schirbel A; Buck AK; Lassmann M
J Nucl Med; 2015 Mar; 56(3):410-6. PubMed ID: 25698782
[TBL] [Abstract][Full Text] [Related]
28. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.
Petersen AL; Henriksen JR; Binderup T; Elema DR; Rasmussen PH; Hag AM; Kjær A; Andresen TL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):941-952. PubMed ID: 26646780
[TBL] [Abstract][Full Text] [Related]
30. Facile synthesis and
Walker D; Li Y; Roxin Á; Schaffer P; Adam MJ; Perrin DM
Bioorg Med Chem Lett; 2016 Oct; 26(20):5126-5131. PubMed ID: 27623550
[TBL] [Abstract][Full Text] [Related]
31. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
32. Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.
Persson M; El Ali HH; Binderup T; Pfeifer A; Madsen J; Rasmussen P; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):290-5. PubMed ID: 24533988
[TBL] [Abstract][Full Text] [Related]
33. Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of
Ren Q; Mohri K; Warashina S; Wada Y; Watanabe Y; Mukai H
Mol Pharm; 2019 Mar; 16(3):1065-1073. PubMed ID: 30633529
[TBL] [Abstract][Full Text] [Related]
34. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
35. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and Preclinical Evaluation of a
Li H; Yuan L; Long Y; Fang H; Li M; Liu Q; Xia X; Qin C; Zhang Y; Lan X; Gai Y
Mol Pharm; 2020 Aug; 17(8):3000-3008. PubMed ID: 32544337
[TBL] [Abstract][Full Text] [Related]
37. Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis.
Zhu Q; Barnes CE; Mannes PZ; Latoche JD; Day KE; Nedrow JR; Novelli EM; Anderson CJ; Tavakoli S
EJNMMI Res; 2023 Jun; 13(1):55. PubMed ID: 37273103
[TBL] [Abstract][Full Text] [Related]
38. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging.
Peng L; Liu R; Marik J; Wang X; Takada Y; Lam KS
Nat Chem Biol; 2006 Jul; 2(7):381-9. PubMed ID: 16767086
[TBL] [Abstract][Full Text] [Related]
39. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
40. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
